Colorectal Cancer
Disease and Advanced Drug Delivery Strategies
- 1st Edition - November 20, 2023
- Imprint: Academic Press
- Editors: Bhupendra G. Prajapati, Anil K. Philip, Sankha Bhattacharya
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 1 3 8 7 0 - 6
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 2 8 6 2 4 - 7
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 1 3 8 7 1 - 3
Colorectal Cancer: Disease and Advanced Drug Delivery Strategies examines the combined impact of basic clinical and medical treatments as well as recent advances in the field… Read more
Purchase options
Colorectal Cancer: Disease and Advanced Drug Delivery Strategies examines the combined impact of basic clinical and medical treatments as well as recent advances in the field of colorectal cancer. With a strong focus towards colorectal cancer diagnosis, disease drug delivery, and diagnosis, the book also examines the Tumor microenvironment-responsive and site-specific nanoparticles for cancer theragnostics. Sections provide the opportunity to understand and diagnose the disease, describes screening methods, and update on drugs, including nano- and immunotherapy. Content includes clinical trials in colorectal cancer research and disease models that help better direct researchers and clinicians on how to diagnose and treat colorectal cancer.
- Provides a wealth of information on the latest research and developments in the science and treatment of colorectal cancer
- Contains new and innovative ways to treat colorectal cancer
- Reflects on basic clinical and medical methods and recent advances in colorectal cancer science
- Gives specific details about how nanoparticles can be used to target cancer cells or cancer treatment
- Covers tumor microenvironment, their challenges, and opportunities in colorectal cancer research
Researchers and graduate students on cancer research and bioinformatics, oncologists, Nano drug delivery systems, Pharmaceutical, Nano-material Sciences and Medical, Nursing, and other health care professionals, Clinical researchers
1. Colorectal Cancer: Understanding of disease
2. Impact of the microbiome on colorectal cancer development
3. Advanced Microfluidic Systems for the colorectal cancer diagnosis and its clinical application
4. Transarterial radioembolization and its impacts on colon cancer treatment and diagnosis
5. Current drug therapy in Colorectal Cancer
6. Recent advancements in Immunotherapy in colon cancer targeting
7. Novel targeting formulations in Colorectal Cancer
8. Polymeric nanoparticles in Colorectal Cancer
9. Lipid nanoparticles in Colorectal Cancer
10. Micro, nano emulsions in Colorectal Cancer
11. A unique compilation of Whole-Systems approaches to curtail colon cancer through Herbal Medicine
12. Bacteriotherapy in Colorectal cancer
13. Biomarker and theranostic in colorectal cancer
14. Advance precision medicine to combat colorectal cancer
15. Recent updates of clinical trials for Colorectal Cancer
16. Disease Models in Colorectal Cancer Research
17. An Outlook into Liposomal Drug Delivery of Chemotherapeutic Agents to Combat Colorectal Cancer
18. Novel targeting strategies on signaling pathway-Responsible for colorectal cancer
19. Decipher the role of Cancer Stem Cells in Colorectal Cancer based on molecular pathology and its clinical significance
2. Impact of the microbiome on colorectal cancer development
3. Advanced Microfluidic Systems for the colorectal cancer diagnosis and its clinical application
4. Transarterial radioembolization and its impacts on colon cancer treatment and diagnosis
5. Current drug therapy in Colorectal Cancer
6. Recent advancements in Immunotherapy in colon cancer targeting
7. Novel targeting formulations in Colorectal Cancer
8. Polymeric nanoparticles in Colorectal Cancer
9. Lipid nanoparticles in Colorectal Cancer
10. Micro, nano emulsions in Colorectal Cancer
11. A unique compilation of Whole-Systems approaches to curtail colon cancer through Herbal Medicine
12. Bacteriotherapy in Colorectal cancer
13. Biomarker and theranostic in colorectal cancer
14. Advance precision medicine to combat colorectal cancer
15. Recent updates of clinical trials for Colorectal Cancer
16. Disease Models in Colorectal Cancer Research
17. An Outlook into Liposomal Drug Delivery of Chemotherapeutic Agents to Combat Colorectal Cancer
18. Novel targeting strategies on signaling pathway-Responsible for colorectal cancer
19. Decipher the role of Cancer Stem Cells in Colorectal Cancer based on molecular pathology and its clinical significance
- Edition: 1
- Published: November 20, 2023
- Imprint: Academic Press
- Language: English
BP
Bhupendra G. Prajapati
Dr. Bhupendra Gopalbhai Prajapati is a Professor (Research Cadre) at Parul Institute of Pharmacy, Parul University, Gujarat, India. He is also acting as Adjunct Professor at Department of Industrial Pharmacy, Faculty of Pharmacy, Silpakorn University, Thailand. With over 22 years of experience in academia, research, and industry, he specializes in lipid-based formulations, nano/microparticulate drug delivery, and bioavailability enhancement. A recipient of several prestigious awards including the AICTE Young Teacher Award and Ganpat University's Staff Excellence honors, Dr. Prajapati has published over 350 research/review papers, and has contributed to more than 170 book chapters. He actively mentors Ph.D. and PG scholars and serves as editor or section editor for several international publications in pharmaceutical sciences.
Affiliations and expertise
Professor (Research Cadre) at Parul Institute of Pharmacy, Parul University, Gujarat, India; Adjunct Professor at Department of Industrial Pharmacy, Faculty of Pharmacy, Silpakorn University, ThailandAP
Anil K. Philip
Dr. Anil Philip is currently working as Associate Dean (Head), School of Pharmacy, University of Nizwa, Oman. Among other credentials, he served as a member of the Health and Social Sciences sectorial grant committee of The Research Council, Oman, and as Faculty Mentored Undergraduate Research Program general supervisor to promote undergraduate research at the University of Nizwa. His research objectives and achievements have been in controlling/modifying the release of small/large molecules targeted to GI space using phase-transited delivery systems. He has worked extensively in the field of controlled/ modified drug release systems. Currently, his research focuses on developing nano-drug delivery systems, which can be targeted to the various body organs. He has guided students in areas of targeted drug delivery, has more than 40 original research publications in international peer-reviewed journals, and two patents on drug delivery systems.
Affiliations and expertise
Associate Dean (Head), School of Pharmacy, University of Nizwa, OmanSB
Sankha Bhattacharya
Dr. Sankha Bhattacharya did his Post Doctorate from the Indian Institute of Technology (BHU), Varanasi, INDIA (August 2018-August 2019) in cancer nanomedicine and molecular pharmaceutics. He is currently serving as an Associate Professor in the Department of Pharmaceutics, School of Pharmacy & Technology Management Shirpur, SVKM'S NMIMS Deemed-to-be University, India with 9.3 years of Research and Teaching experiences. He has published more than 32 national and 18 international papers in high impact factor and peer-reviewed journals. He also published five book chapters on the global platform.
Affiliations and expertise
Associate Professor, Department of Pharmaceutics, School of Pharmacy and Technology Management, SVKM'S NMIMS Deemed-to-be University, Shirpur, Maharashtra, IndiaRead Colorectal Cancer on ScienceDirect